×
For best experience we recommend to activate Javascript in your browser.
Recombinant MAP2K5 antibody (Alexa Fluor 680)
The Alexa Fluor 680-conjugated Rabbit Monoclonal anti-MAP2K5 antibody (ABIN7785364) specifically detects MAP2K5 in WB, IF and ICC.
The antibody is reactive with Human samples.
Catalog No. ABIN7785364
$438.90
Plus shipping costs $50.00
Delivery in 6 to 8 Business Days
Quick Overview for Recombinant MAP2K5 antibody (Alexa Fluor 680) (ABIN7785364)
Target
See all MAP2K5 Antibodies
MAP2K5
(Mitogen-Activated Protein Kinase Kinase 5 (MAP2K5))
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for MAP2K5 antibodies
Human
Host
All hosts for MAP2K5 antibodies
Rabbit
Clonality
All clonalities for MAP2K5 antibodies
Monoclonal
Conjugate
All conjugates for MAP2K5 antibodies
This MAP2K5 antibody is conjugated to Alexa Fluor 680
Application
All applications for MAP2K5 antibodies
Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)
Product Details anti-MAP2K5 Antibody (Alexa Fluor 680)
(hide)
Purpose
Conjugated MEK5 Rabbit mAb
Specificity
MEK5 Antibody detects endogenous levels of MEK5
Purification
Affinity-chromatography
Immunogen
A synthesized peptide derived from human MEK5
Alternatives
(show)
Application Details
(hide)
Application Notes
most applications: 1: 50 - 1: 250
Restrictions
For Research Use only
Handling
(hide)
Buffer
Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Protect from light!
Storage
4 °C
Storage Comment
Store at 4°C in dark for 6 months
Target Details for MAP2K5
(hide)
Target
MAP2K5
(Mitogen-Activated Protein Kinase Kinase 5 (MAP2K5))
Alternative Name
MEK5
Background
MAP2K5, HsT17454, MAPKK 5, MEK 5, MAPKK5, MEK5, MKK5, MAP kinase kinase 5, PRKMK5, MAP kinase kinase MEK5b, MAPK/ERK kinase 5,
UniProt
Q13163
Pathways
MAPK Signaling , Neurotrophin Signaling Pathway
Recently viewed
(hide)
Chat with us , powered by LiveChat